In Phase A, individuals will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental individuals will likely be enrolled within the identified monotherapy dosign regimen. In Section B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "add-on" therapy. In Segment https://abbv-744safetyandsideeffe13568.blog2news.com/32628718/abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc-options